ArticlemBio2024
SARS-CoV-2 infection predisposes patients to coinfection with
Abstract read
In one paragraph
Article in mBio, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Methicillin-resistant Staphylococcus aureus.Nature reviews. Disease primers · 2026Review
- Risk Factors of Secondary Bacterial Infection in Patients Hospitalized with COVID-19.Journal of clinical medicine · 2026Article
- mGem: Population genomics ofmBio · 2026Article
- Type I and III interferons synergize with TNF to promote virally-triggered damage to the intestinal epithelium.bioRxiv : the preprint server for biology · 2026Article
- Respiratory Virus Coinfection Is a Risk Factor for Adverse Outcomes DuringOpen forum infectious diseases · 2026Article
- Comparative progress on the mechanisms of airway mucosal injury induced by different pathogens: SARS-CoV-2, influenza A virus, and Mycoplasma pneumoniae.Frontiers in cellular and infection microbiology · 2026Review
- Airway immunometabolic responses during pulmonary bacterial and viral infections.Cell reports · 2025Review
- Quality Management Outweighs Pandemic: Retrospective Analysis Shows Improved Quality of Care forDiseases (Basel, Switzerland) · 2025Article
- Data Mining Models in Prediction of Vancomycin-IntermediateMicroorganisms · 2025Article
- Changes in children respiratory infections pre and post COVID-19 pandemic.Frontiers in cellular and infection microbiology · 2025Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
37 authors.
Ashira Lubkin *Department of Microbiology, New York University Grossman School of Medicine, New York, New York, USA.ORCID 0000-0002-0271-0562
Lucie Bernard-Raichon *Department of Microbiology, New York University Grossman School of Medicine, New York, New York, USA.
Ashley L DuMont *Department of Microbiology, New York University Grossman School of Medicine, New York, New York, USA.
Ana Mayela Valero Jimenez *Department of Microbiology, New York University Grossman School of Medicine, New York, New York, USA.
Gregory G PutzelDepartment of Microbiology, New York University Grossman School of Medicine, New York, New York, USA.
Juan GagoDepartment of Population Health, New York University Grossman School of Medicine, New York, New York, USA.
Erin E ZwackDepartment of Microbiology, New York University Grossman School of Medicine, New York, New York, USA.
Olufolakemi OlusanyaDepartment of Microbiology, New York University Grossman School of Medicine, New York, New York, USA.
Kristina M BoguslawskiDepartment of Microbiology, New York University Grossman School of Medicine, New York, New York, USA.
Simone DallariDepartment of Microbiology, New York University Grossman School of Medicine, New York, New York, USA.
Sophie DyzenhausDepartment of Microbiology, New York University Grossman School of Medicine, New York, New York, USA.
Christin HerrmannDepartment of Microbiology, New York University Grossman School of Medicine, New York, New York, USA.
Juliana K IlmainDepartment of Microbiology, New York University Grossman School of Medicine, New York, New York, USA.
Georgia L IsomDepartment of Microbiology, New York University Grossman School of Medicine, New York, New York, USA.
Miranda PawlineDepartment of Microbiology, New York University Grossman School of Medicine, New York, New York, USA.
Andrew I PeraultDepartment of Microbiology, New York University Grossman School of Medicine, New York, New York, USA.
Sofya PerelmanDepartment of Microbiology, New York University Grossman School of Medicine, New York, New York, USA.
William E SauseDepartment of Microbiology, New York University Grossman School of Medicine, New York, New York, USA.
Ifrah ShahiDepartment of Microbiology, New York University Grossman School of Medicine, New York, New York, USA.
Amelia St JohnDepartment of Microbiology, New York University Grossman School of Medicine, New York, New York, USA.
Rebecca TierceDivision of Comparative Medicine, New York University Langone Health, New York, New York, USA.
Xuhui ZhengDepartment of Microbiology, New York University Grossman School of Medicine, New York, New York, USA.
Chunyi ZhouDepartment of Microbiology, New York University Grossman School of Medicine, New York, New York, USA.
Maria G NovalDepartment of Microbiology, New York University Grossman School of Medicine, New York, New York, USA.
Anna O'KeeffeDepartment of Microbiology, New York University Grossman School of Medicine, New York, New York, USA.
Magda PodkowikDepartment of Microbiology, New York University Grossman School of Medicine, New York, New York, USA.
Sandra GonzalesDepartment of Microbiology, New York University Grossman School of Medicine, New York, New York, USA.
Kenneth InglimaDepartment of Medicine, NYU Grossman School of Medicine, New York, New York, USA.
Ludovic DesvignesDepartment of Medicine, NYU Grossman School of Medicine, New York, New York, USA.
Sarah E HochmanAntimicrobial-Resistant Pathogens Program, Microbial Genomics Core Lab, New York University Langone Health, New York, New York, USA.
Kenneth A StaplefordDepartment of Microbiology, New York University Grossman School of Medicine, New York, New York, USA.ORCID 0000-0002-7796-2254
Lorna E ThorpeDepartment of Population Health, New York University Grossman School of Medicine, New York, New York, USA.
Alejandro PirontiDepartment of Microbiology, New York University Grossman School of Medicine, New York, New York, USA.
Bo Shopsin *Department of Microbiology, New York University Grossman School of Medicine, New York, New York, USA.
Ken Cadwell *Division of Gastroenterology and Hepatology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Meike Dittmann *Department of Microbiology, New York University Grossman School of Medicine, New York, New York, USA.ORCID 0000-0002-1741-7916
Victor J Torres *Department of Microbiology, New York University Grossman School of Medicine, New York, New York, USA.ORCID 0000-0002-7126-0489
Funding
Mechanistic Studies Of The Staphylococcus aureus LukAB CytotoxinR01AI099394 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Victor J. Torres · 2013 to 2026
$6.1MContribution of LukED to Staphylococcus aureus pathobiologyR01AI105129 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI TORRES, VICTOR J. · 2014 to 2023
$4.9MMechanisms of MRSA intestinal colonizationR01AI140754 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SHOPSIN, BO · 2020 to 2024
$3.5MHost-pathogen interactions during hospital adaptation of MRSAR01AI137336 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SHOPSIN, BO, YANAI, ITAI · 2019 to 2022
$3.3MUC San Diego RAPID Faculty Development Program in Infectious DiseasesR25AI147376 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ADRIANA H TREMOULET, Joann Trejo · 2020 to 2026
$2.5MELF1 - Molecular mechanisms of a novel transcription factor with broad antiviral activityR01AI143639 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI WEISER, JEFFREY NEAL · 2019 to 2023
$2.5MHHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) AI099394HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) AI105129HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) AI137336HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) AI140754HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) AI143639NIAID NIH HHS R01 AI099394NIAID NIH HHS R01 AI105129NIAID NIH HHS R01 AI137336NIAID NIH HHS R01 AI140754NIAID NIH HHS R01 AI143639NIAID NIH HHS R25 AI147376
Abstract
Severe COVID-19 has been associated with coinfections with bacterial and fungal pathogens. Notably, patients with COVID-19 who develop IMPORTANCE: The COVID-19 pandemic has had an enormous impact on healthcare across the globe. Patients who were severely infected with SARS-CoV-2, the virus causing COVID-19, sometimes became infected with other pathogens, which is termed coinfection. If the coinfecting pathogen is the bacterium
Indexed as
CoinfectionCOVID-19SARS-CoV-2Staphylococcal InfectionsStaphylococcus aureusAgedAnimalsBacteremiaDisease Models, AnimalFemaleHumansMaleMiceMiddle AgedNew York CityPhylogenyagrcoinfectionCOVIDMRSASARS-CoV-2
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.